DRUG · Mapped RxNorm record
Metformin
Normalized identity: metforminView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Effects of Fatty Acid Delivery on Heart Metabolism and Function in Type 2 Diabetes (T2DM
NCT00577590
Drugs and interventions used in this trial
3 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Rosiglitazone
Normalized identity: rosiglitazoneView linked drug · Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Lovaza
Normalized identity: LovazaView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedEffects of Fatty Acid Delivery on Heart Metabolism and Function in Type 2 Diabetes (T2DM
Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
MetforminDRUG · verified · RxNorm: metformin
RosiglitazoneDRUG · verified · RxNorm: rosiglitazone
LovazaDRUG · verified · RxNorm: Lovaza
Sponsors & collaborators
Washington University School of Medicinelead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00577590 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.